首页> 外国专利> Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor

Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor

机译:鉴定患有卵巢癌的可能性增加的患者的方法及其组合物

摘要

Screening methods for identifying patients with an increased likelihood of having ovarian cancer are provided. The screening methods involve the detection of expression of a plurality of biomarkers in a body sample, wherein overexpression of the biomarkers is indicative of an increased likelihood of having ovarian cancer. The screening methods may further comprise a two-step analysis. Biomarkers of interest include genes and proteins that are, for example, involved in defects in DNA replication/cell cycle control, cell growth and proliferation, escape from apoptosis, angiogenesis or lymphogenesis, or the mechanisms of cancer cell motility and invasion. In some aspects of the invention, expression of a biomarker is detected at the protein level using a biomarker-specific antibody or at the nucleic acid level using nucleic acid hybridization techniques. Methods for detecting ovarian cancer in patients are further disclosed herein. Kits for practicing the methods of the invention are further provided.
机译:提供了用于鉴定患有卵巢癌的可能性增加的患者的筛选方法。筛选方法涉及检测身体样品中多种生物标志物的表达,其中生物标志物的过表达指示患有卵巢癌的可能性增加。筛选方法可以进一步包括两步分析。感兴趣的生物标记包括例如与DNA复制/细胞周期控制中的缺陷,细胞生长和增殖,逃避凋亡,血管生成或淋巴生成或癌细胞运动和侵袭机制有关的基因和蛋白质。在本发明的一些方面,使用生物标志物特异性抗体在蛋白质水平上检测生物标志物的表达,或者使用核酸杂交技术在核酸水平上检测生物标志物的表达。本文进一步公开了用于检测患者的卵巢癌的方法。还提供了用于实施本发明方法的试剂盒。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号